Picture a coordinator’s Tuesday morning: three queries aging past 14 days in the EDC, an IRT system she was trained on last week that still requires a sponsor-side ticket to reset, two informed consent visits scheduled back-to-back with a new patient who has driving anxiety and needs an escort arranged, and a protocol amendment that landed Friday afternoon requiring an IRB submission with a two-day turnaround request from the CRA. She has not called the four pre-screened patients on her list. She will not get to them today.
This is not a morale story. This is an enrollment story.
The operational chain between coordinator capacity and patient accrual is shorter and more mechanical than most sponsor-side teams acknowledge. When the person responsible for scheduling, consenting, and retaining patients runs out of hours, patients do not get called back — and the slots that looked green on the enrollment tracker go dark. The MedCity News analysis of clinical operations burnout names what site directors have been watching for two years: documentation burden, scheduling load, and data reconciliation together are consuming the time that used to belong to patients.
What the Workload Numbers Actually Show
The numbers behind this pattern are not soft. A published analysis of CRC effort allocation found that roughly 25–30% of a coordinator’s capacity disappears before a single patient interaction — absorbed by general office work, administrative obligations, and non-study activity. Layer a high-volume site running four or five concurrent protocols on top of that baseline, and the math against patient-facing time becomes brutal. Enrollment plans are typically built assuming a coordinator has somewhere between six and eight productive hours per day pointed at the trial. Most sites will tell you the real number is closer to three.
Technology was supposed to fix this. It has not. According to an Advarra industry survey, 55% of sites rated technology as the single biggest challenge in study startup — and two-thirds reported that setup and training on sponsor technology has become more burdensome compared to five years ago. Nearly 60% of sites said their study volume is higher than it was previously. More protocols, more systems, more training overhead, no proportional increase in coordinator headcount. That combination does not produce efficiency; it produces exhaustion.
Sites I work with across the CliniBiz network flag the same friction point repeatedly: vendor consolidation at the sponsor level often means a coordinator is now logging into a different system for EDC, IRT, eCOA, and central lab notifications — each with its own password reset protocol, its own training module, and its own help desk ticket queue. The time cost of that fragmentation is invisible in a sponsor’s operational plan but very visible on a coordinator’s calendar. An SIV training day that runs to six hours leaves no buffer for a screen call that afternoon. The patient who does not get called that day may not pick up next week.
Where Activation and Amendment Cycles Break Down
Coordinator overload shows up first in startup, which is where it does the most structural damage. The two standard benchmarks — 45 days to site activation for an experienced site on a familiar therapeutic area, 90 days as the outer bound before a site is considered struggling — both assume a coordinator who can prioritize the activation checklist without competition from five other active protocols. When that assumption breaks, startup timelines slip not because of IRB turnaround or contract negotiation, but because the site cannot get through the protocol training sign-off, the delegation log, and the system access confirmations on schedule. None of these tasks are hard. All of them require uninterrupted time that does not exist.
Protocol amendments expose the same fracture line. ICH E6(R3) section 5.2 places clear responsibility on the sponsor to ensure sites have adequate resources to conduct the trial — but when an amendment drops midway through enrollment with a 10-day implementation window, the operational burden lands entirely on the coordinator. She needs to update the ICF, submit to the IRB, retrain on the revised procedures, and document the training. If she is already at capacity, something slips. The deviation that follows is usually logged as a site performance issue. The root cause is a staffing equation that was never solved upstream.
The economics of a failed enrollment period are rarely traced back to coordinator capacity, but the arithmetic is direct. If a site projects 2.5 patients per month and delivers 1.2 because call-back time collapsed, the per-patient cost for that site rises — and the sponsor either extends the trial timeline or activates a rescue site, both of which cost more than a coordinator stipend increase would have. Screen failure rates compound this: sites running above a 40% screen failure rate are spending coordinator hours on patients who never enroll, which accelerates fatigue and compresses the time available for the patients who will. Underfunding coordinator support to protect per-patient budgets is a false economy with a delayed but measurable invoice.
What Changes Monday Morning
For site directors and coordinators: the document that protects you in an inspection and the document that protects your enrollment are the same one — the delegation log, kept current, that shows staffing coverage for every protocol role. If a coordinator leaves and coverage is not formally reassigned within 48 hours, you have both a GCP documentation gap and a patient contact gap. Treat coordinator transitions as site activation events with the same urgency as a first-patient-in deadline. Assign a backup contact name on every open subject’s record before the outgoing coordinator’s last day.
For sponsors and CTMs: the pre-startup feasibility call you run before site selection should include one direct question to the site coordinator — not the PI, not the site director — about current protocol load and technology training burden. A coordinator managing four active protocols who is being asked to add a fifth with a proprietary ePRO system and a new IRT platform is a retention risk embedded in your enrollment plan. Adding a technology burden assessment to your site readiness checklist, alongside the standard ICH E6(R3) Section 4.2 investigator qualification review, gives you an early signal before activation rather than a rescue call at month three.
The trials that finish on time are almost always the ones where someone on the sponsor side noticed, early, that the coordinator was running out of runway — and did something about it before the enrollment chart showed the consequence.
